Cargando…

Olopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety

OBJECTIVE: To compare the efficacy and safety of olopatadine and rupatadine in seasonal allergic rhinitis (SAR). MATERIALS AND METHODS: A 2-week, single-centered, randomized, open, parallel group comparative clinical study was conducted on patients with SAR. Following inclusion and exclusion criteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maiti, Rituparna, Jaida, Jyothirmai, Rahman, Jalelur, Gaddam, Rajasri, Palani, Anuradha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198523/ https://www.ncbi.nlm.nih.gov/pubmed/22025856 http://dx.doi.org/10.4103/0976-500X.85958

Ejemplares similares

Topical Olopatadine Hydrochloride versus Ketotifen Fumarate for Allergic Conjunctivitis
por: Patel, Dharmistha, et al.
Publicado: (2018)

Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes
por: Liu, Yu, et al.
Publicado: (2022)

FUTURA STUDY-Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis
por: de Godoy Mion, Olavo, et al.
Publicado: (2015)

Racemic salbutamol and levosalbutamol in mild persistent asthma: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double-blind, parallel group study
por: Dakhale, Ganesh, et al.
Publicado: (2016)

Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety
por: Maiti, Rituparna, et al.
Publicado: (2011)

Cardioprotective role of insulin: Advantage analogues
por: Maiti, Rituparna, et al.
Publicado: (2012)

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
por: Uchio, Eiichi
Publicado: (2008)

Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
por: Mullol, Joaquim, et al.
Publicado: (2019)

The effectiveness of olopatadine hydrochloride eye drops for allergic conjunctivitis: Protocol for a systematic review
por: Zi, Yingxin, et al.
Publicado: (2020)

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
por: McLaurin, Eugene, et al.
Publicado: (2017)

Intestinal Anisakiasis Treated Successfully with Prednisolone and Olopatadine Hydrochloride
por: Toyoda, Hideki, et al.
Publicado: (2016)

Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study
por: Fifer, Simon, et al.
Publicado: (2023)

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model
por: Torkildsen, Gail, et al.
Publicado: (2015)

Comparison of Efficacy, Safety and Cost-effectiveness of Rupatadine and Olopatadine in Patients of Chronic Spontaneous Urticaria: A Randomized, Double-blind, Comparative, Parallel Group Trial
por: Dakhale, Ganesh N, et al.
Publicado: (2016)

Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study
por: Santamaría, Eva, et al.
Publicado: (2018)

Loratadine versus levocetirizine in chronic idiopathic urticaria: A comparative study of efficacy and safety
por: Anuradha, P., et al.
Publicado: (2010)

Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
por: Ayyappanavar, Shruti, et al.
Publicado: (2021)

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
por: Mizoguchi, Takanori, et al.
Publicado: (2017)

Rupatadine
por: Kaur, Manpreet, et al.
Publicado: (2013)

Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial
por: Okubo, Kimihiro, et al.
Publicado: (2019)

Utilization of Ethylcellulose Microparticles with Rupatadine Fumarate in Designing Orodispersible Minitablets with Taste Masking Effect
por: Wasilewska, Katarzyna, et al.
Publicado: (2020)

Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study
por: Santamaria, Eva, et al.
Publicado: (2021)

Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle‐controlled study
por: Liu, Rui‐fen, et al.
Publicado: (2016)

Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria
por: Makino, Teruhiko, et al.
Publicado: (2012)

Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
por: Valero, Antonio, et al.
Publicado: (2020)

Effect of fexofenadine hydrochloride on allergic rhinitis aggravated by air pollutants
por: Ellis, Anne K., et al.
Publicado: (2021)

Comparison of olopatadine with ketotifen for allergic conjunctivitis: a meta-analysis study
por: Li, Shiyu, et al.
Publicado: (2023)

Therapeutic effects of Houttuynia eye drops combined with olopatadine hydrochloride eye drops on vernal keratoconjunctivitis
por: Xu, Xuegu, et al.
Publicado: (2019)

Rupatadine oral solution improves rhino-conjunctive symptoms control in children with 6-11 years weighing ≥25 kg with persistent allergic rhinitis
por: Izquierdo, Iñaki, et al.
Publicado: (2013)

Orodispersible Films with Rupatadine Fumarate Enclosed in Ethylcellulose Microparticles as Drug Delivery Platform with Taste-Masking Effect
por: Olechno, Katarzyna, et al.
Publicado: (2022)

Comparison of pharmacokinetics and safety characteristics between two olopatadine hydrochloride 5 mg tablet formulations in healthy Korean subjects
por: Kim, Jae Hoon, et al.
Publicado: (2021)

Effects of Olopatadine Hydrochloride, a Histamine H(1) Receptor Antagonist, on Histamine-Induced Skin Responses
por: Hashimoto, Takashi, et al.
Publicado: (2010)

New guidelines for the treatment of seasonal allergic rhinitis
por: Emeryk, Andrzej, et al.
Publicado: (2019)

Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis
por: Chennakeshavaraju, Nandish, et al.
Publicado: (2020)

A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
por: Lukat, KF, et al.
Publicado: (2013)

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies
por: Meier, Edward, et al.
Publicado: (2017)

Investigation of the antiallergic activity of olopatadine on rhinitis induced by intranasal instillation of antigen in sensitized rats using thermography
por: Tamura, Tadafumi
Publicado: (2011)

Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
por: Ellis, Anne K., et al.
Publicado: (2021)

OLOPATADINE IN CHRONIC IDIOPATHIC URTICARIA
por: Godse, Kiran V
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sam6ao0gvh5m9gppfq8m428e6v